On the PDX data, both the onco-type DX DCIS and 812-gene classifiers showed significant prediction of DCIS progression, whereas the COX2+P16+ Ki67+ showed a trend toward a higher risk of invasive progression (Figures 3C and S3F). Here, MKI67 is linked to ductal breast carcinoma in situ.